nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—CYP3A4—Thiotepa—urinary bladder cancer	0.248	0.687	CbGbCtD
Flucloxacillin—CYP3A4—Etoposide—urinary bladder cancer	0.0674	0.186	CbGbCtD
Flucloxacillin—CYP3A4—Doxorubicin—urinary bladder cancer	0.0459	0.127	CbGbCtD
Flucloxacillin—Leukopenia—Fluorouracil—urinary bladder cancer	0.00182	0.00285	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00179	0.0028	CcSEcCtD
Flucloxacillin—Anaemia—Cisplatin—urinary bladder cancer	0.00178	0.00279	CcSEcCtD
Flucloxacillin—Dyspepsia—Thiotepa—urinary bladder cancer	0.00176	0.00276	CcSEcCtD
Flucloxacillin—Convulsion—Fluorouracil—urinary bladder cancer	0.00176	0.00276	CcSEcCtD
Flucloxacillin—Arthralgia—Gemcitabine—urinary bladder cancer	0.00176	0.00275	CcSEcCtD
Flucloxacillin—Myalgia—Gemcitabine—urinary bladder cancer	0.00176	0.00275	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00175	0.00274	CcSEcCtD
Flucloxacillin—Decreased appetite—Thiotepa—urinary bladder cancer	0.00174	0.00273	CcSEcCtD
Flucloxacillin—Discomfort—Gemcitabine—urinary bladder cancer	0.00174	0.00272	CcSEcCtD
Flucloxacillin—Malaise—Cisplatin—urinary bladder cancer	0.00174	0.00272	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00173	0.00271	CcSEcCtD
Flucloxacillin—Myalgia—Fluorouracil—urinary bladder cancer	0.00173	0.00271	CcSEcCtD
Flucloxacillin—Dysgeusia—Etoposide—urinary bladder cancer	0.00173	0.00271	CcSEcCtD
Flucloxacillin—Leukopenia—Cisplatin—urinary bladder cancer	0.00172	0.0027	CcSEcCtD
Flucloxacillin—Constipation—Thiotepa—urinary bladder cancer	0.00171	0.00268	CcSEcCtD
Flucloxacillin—Discomfort—Fluorouracil—urinary bladder cancer	0.00171	0.00268	CcSEcCtD
Flucloxacillin—Purpura—Epirubicin—urinary bladder cancer	0.0017	0.00267	CcSEcCtD
Flucloxacillin—Vascular purpura—Doxorubicin—urinary bladder cancer	0.0017	0.00266	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00168	0.00264	CcSEcCtD
Flucloxacillin—Convulsion—Cisplatin—urinary bladder cancer	0.00167	0.00261	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00166	0.0026	CcSEcCtD
Flucloxacillin—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00165	0.00259	CcSEcCtD
Flucloxacillin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00165	0.00259	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00165	0.00258	CcSEcCtD
Flucloxacillin—Myalgia—Cisplatin—urinary bladder cancer	0.00164	0.00257	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00164	0.00257	CcSEcCtD
Flucloxacillin—Skin disorder—Gemcitabine—urinary bladder cancer	0.00164	0.00256	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00164	0.00256	CcSEcCtD
Flucloxacillin—Anaemia—Etoposide—urinary bladder cancer	0.00163	0.00255	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00163	0.00255	CcSEcCtD
Flucloxacillin—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00162	0.00255	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00162	0.00254	CcSEcCtD
Flucloxacillin—Discomfort—Cisplatin—urinary bladder cancer	0.00162	0.00254	CcSEcCtD
Flucloxacillin—Urticaria—Thiotepa—urinary bladder cancer	0.00159	0.00249	CcSEcCtD
Flucloxacillin—Malaise—Etoposide—urinary bladder cancer	0.00159	0.00249	CcSEcCtD
Flucloxacillin—Abdominal pain—Thiotepa—urinary bladder cancer	0.00158	0.00248	CcSEcCtD
Flucloxacillin—Body temperature increased—Thiotepa—urinary bladder cancer	0.00158	0.00248	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00158	0.00247	CcSEcCtD
Flucloxacillin—Leukopenia—Etoposide—urinary bladder cancer	0.00158	0.00247	CcSEcCtD
Flucloxacillin—Purpura—Doxorubicin—urinary bladder cancer	0.00158	0.00247	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00157	0.00246	CcSEcCtD
Flucloxacillin—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00154	0.00241	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00154	0.00241	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00154	0.00241	CcSEcCtD
Flucloxacillin—Convulsion—Etoposide—urinary bladder cancer	0.00153	0.00239	CcSEcCtD
Flucloxacillin—Skin disorder—Cisplatin—urinary bladder cancer	0.00153	0.00239	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00151	0.00237	CcSEcCtD
Flucloxacillin—Eosinophilia—Methotrexate—urinary bladder cancer	0.0015	0.00235	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00149	0.00234	CcSEcCtD
Flucloxacillin—Discomfort—Etoposide—urinary bladder cancer	0.00148	0.00232	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00148	0.00232	CcSEcCtD
Flucloxacillin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00148	0.00231	CcSEcCtD
Flucloxacillin—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00146	0.0023	CcSEcCtD
Flucloxacillin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00146	0.00229	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00145	0.00228	CcSEcCtD
Flucloxacillin—Constipation—Gemcitabine—urinary bladder cancer	0.00144	0.00226	CcSEcCtD
Flucloxacillin—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00144	0.00226	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00144	0.00225	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00143	0.00224	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00143	0.00224	CcSEcCtD
Flucloxacillin—Neutropenia—Methotrexate—urinary bladder cancer	0.00142	0.00222	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00141	0.00221	CcSEcCtD
Flucloxacillin—Eosinophilia—Epirubicin—urinary bladder cancer	0.0014	0.0022	CcSEcCtD
Flucloxacillin—Skin disorder—Etoposide—urinary bladder cancer	0.0014	0.00219	CcSEcCtD
Flucloxacillin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00139	0.00218	CcSEcCtD
Flucloxacillin—Diarrhoea—Thiotepa—urinary bladder cancer	0.00137	0.00215	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00137	0.00214	CcSEcCtD
Flucloxacillin—Decreased appetite—Cisplatin—urinary bladder cancer	0.00137	0.00214	CcSEcCtD
Flucloxacillin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00137	0.00214	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00136	0.00212	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00134	0.0021	CcSEcCtD
Flucloxacillin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00133	0.00209	CcSEcCtD
Flucloxacillin—Renal failure—Methotrexate—urinary bladder cancer	0.00133	0.00208	CcSEcCtD
Flucloxacillin—Neutropenia—Epirubicin—urinary bladder cancer	0.00133	0.00208	CcSEcCtD
Flucloxacillin—Dizziness—Thiotepa—urinary bladder cancer	0.00132	0.00208	CcSEcCtD
Flucloxacillin—Urticaria—Fluorouracil—urinary bladder cancer	0.00132	0.00206	CcSEcCtD
Flucloxacillin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00131	0.00205	CcSEcCtD
Flucloxacillin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.0013	0.00204	CcSEcCtD
Flucloxacillin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00129	0.00203	CcSEcCtD
Flucloxacillin—Haematuria—Methotrexate—urinary bladder cancer	0.00129	0.00202	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.00128	0.002	CcSEcCtD
Flucloxacillin—Vomiting—Thiotepa—urinary bladder cancer	0.00127	0.002	CcSEcCtD
Flucloxacillin—Rash—Thiotepa—urinary bladder cancer	0.00126	0.00198	CcSEcCtD
Flucloxacillin—Dermatitis—Thiotepa—urinary bladder cancer	0.00126	0.00198	CcSEcCtD
Flucloxacillin—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00126	0.00198	CcSEcCtD
Flucloxacillin—Headache—Thiotepa—urinary bladder cancer	0.00125	0.00197	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00125	0.00196	CcSEcCtD
Flucloxacillin—Decreased appetite—Etoposide—urinary bladder cancer	0.00125	0.00196	CcSEcCtD
Flucloxacillin—Renal failure—Epirubicin—urinary bladder cancer	0.00124	0.00195	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00124	0.00195	CcSEcCtD
Flucloxacillin—Body temperature increased—Cisplatin—urinary bladder cancer	0.00124	0.00195	CcSEcCtD
Flucloxacillin—Jaundice—Epirubicin—urinary bladder cancer	0.00123	0.00193	CcSEcCtD
Flucloxacillin—Constipation—Etoposide—urinary bladder cancer	0.00123	0.00193	CcSEcCtD
Flucloxacillin—Neutropenia—Doxorubicin—urinary bladder cancer	0.00123	0.00192	CcSEcCtD
Flucloxacillin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00122	0.00191	CcSEcCtD
Flucloxacillin—Hepatitis—Methotrexate—urinary bladder cancer	0.00121	0.0019	CcSEcCtD
Flucloxacillin—Haematuria—Epirubicin—urinary bladder cancer	0.00121	0.00189	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.0012	0.00188	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.0012	0.00187	CcSEcCtD
Flucloxacillin—Nausea—Thiotepa—urinary bladder cancer	0.00119	0.00186	CcSEcCtD
Flucloxacillin—Urethral disorder—Methotrexate—urinary bladder cancer	0.00119	0.00186	CcSEcCtD
Flucloxacillin—Feeling abnormal—Etoposide—urinary bladder cancer	0.00119	0.00186	CcSEcCtD
Flucloxacillin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00118	0.00185	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00118	0.00184	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00116	0.00182	CcSEcCtD
Flucloxacillin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00116	0.00181	CcSEcCtD
Flucloxacillin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00115	0.00181	CcSEcCtD
Flucloxacillin—Renal failure—Doxorubicin—urinary bladder cancer	0.00115	0.0018	CcSEcCtD
Flucloxacillin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00115	0.0018	CcSEcCtD
Flucloxacillin—Urticaria—Etoposide—urinary bladder cancer	0.00114	0.00179	CcSEcCtD
Flucloxacillin—Jaundice—Doxorubicin—urinary bladder cancer	0.00114	0.00179	CcSEcCtD
Flucloxacillin—Abdominal pain—Etoposide—urinary bladder cancer	0.00114	0.00178	CcSEcCtD
Flucloxacillin—Body temperature increased—Etoposide—urinary bladder cancer	0.00114	0.00178	CcSEcCtD
Flucloxacillin—Hepatitis—Epirubicin—urinary bladder cancer	0.00114	0.00178	CcSEcCtD
Flucloxacillin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00113	0.00178	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00112	0.00176	CcSEcCtD
Flucloxacillin—Haematuria—Doxorubicin—urinary bladder cancer	0.00112	0.00175	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00112	0.00175	CcSEcCtD
Flucloxacillin—Urethral disorder—Epirubicin—urinary bladder cancer	0.00111	0.00174	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.00111	0.00173	CcSEcCtD
Flucloxacillin—Immune system disorder—Methotrexate—urinary bladder cancer	0.0011	0.00172	CcSEcCtD
Flucloxacillin—Dizziness—Fluorouracil—urinary bladder cancer	0.0011	0.00172	CcSEcCtD
Flucloxacillin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00109	0.00171	CcSEcCtD
Flucloxacillin—Diarrhoea—Cisplatin—urinary bladder cancer	0.00107	0.00168	CcSEcCtD
Flucloxacillin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00107	0.00168	CcSEcCtD
Flucloxacillin—Vomiting—Gemcitabine—urinary bladder cancer	0.00107	0.00168	CcSEcCtD
Flucloxacillin—Rash—Gemcitabine—urinary bladder cancer	0.00106	0.00166	CcSEcCtD
Flucloxacillin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00106	0.00166	CcSEcCtD
Flucloxacillin—Hypersensitivity—Etoposide—urinary bladder cancer	0.00106	0.00166	CcSEcCtD
Flucloxacillin—Headache—Gemcitabine—urinary bladder cancer	0.00106	0.00165	CcSEcCtD
Flucloxacillin—Vomiting—Fluorouracil—urinary bladder cancer	0.00105	0.00165	CcSEcCtD
Flucloxacillin—Hepatitis—Doxorubicin—urinary bladder cancer	0.00105	0.00165	CcSEcCtD
Flucloxacillin—Rash—Fluorouracil—urinary bladder cancer	0.00104	0.00164	CcSEcCtD
Flucloxacillin—Dermatitis—Fluorouracil—urinary bladder cancer	0.00104	0.00164	CcSEcCtD
Flucloxacillin—Headache—Fluorouracil—urinary bladder cancer	0.00104	0.00163	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00104	0.00163	CcSEcCtD
Flucloxacillin—Dysgeusia—Methotrexate—urinary bladder cancer	0.00103	0.00162	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00103	0.00162	CcSEcCtD
Flucloxacillin—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00103	0.00161	CcSEcCtD
Flucloxacillin—Immune system disorder—Epirubicin—urinary bladder cancer	0.00103	0.00161	CcSEcCtD
Flucloxacillin—Nausea—Gemcitabine—urinary bladder cancer	0.001	0.00157	CcSEcCtD
Flucloxacillin—Vomiting—Cisplatin—urinary bladder cancer	0.000999	0.00156	CcSEcCtD
Flucloxacillin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000993	0.00156	CcSEcCtD
Flucloxacillin—Rash—Cisplatin—urinary bladder cancer	0.00099	0.00155	CcSEcCtD
Flucloxacillin—Dermatitis—Cisplatin—urinary bladder cancer	0.000989	0.00155	CcSEcCtD
Flucloxacillin—Diarrhoea—Etoposide—urinary bladder cancer	0.000984	0.00154	CcSEcCtD
Flucloxacillin—Nausea—Fluorouracil—urinary bladder cancer	0.000984	0.00154	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00098	0.00154	CcSEcCtD
Flucloxacillin—Anaemia—Methotrexate—urinary bladder cancer	0.000976	0.00153	CcSEcCtD
Flucloxacillin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000968	0.00152	CcSEcCtD
Flucloxacillin—Malaise—Methotrexate—urinary bladder cancer	0.000952	0.00149	CcSEcCtD
Flucloxacillin—Dizziness—Etoposide—urinary bladder cancer	0.000951	0.00149	CcSEcCtD
Flucloxacillin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000949	0.00149	CcSEcCtD
Flucloxacillin—Leukopenia—Methotrexate—urinary bladder cancer	0.000945	0.00148	CcSEcCtD
Flucloxacillin—Nausea—Cisplatin—urinary bladder cancer	0.000933	0.00146	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000917	0.00144	CcSEcCtD
Flucloxacillin—Convulsion—Methotrexate—urinary bladder cancer	0.000915	0.00143	CcSEcCtD
Flucloxacillin—Vomiting—Etoposide—urinary bladder cancer	0.000915	0.00143	CcSEcCtD
Flucloxacillin—Anaemia—Epirubicin—urinary bladder cancer	0.000913	0.00143	CcSEcCtD
Flucloxacillin—Rash—Etoposide—urinary bladder cancer	0.000907	0.00142	CcSEcCtD
Flucloxacillin—Dermatitis—Etoposide—urinary bladder cancer	0.000906	0.00142	CcSEcCtD
Flucloxacillin—Headache—Etoposide—urinary bladder cancer	0.000901	0.00141	CcSEcCtD
Flucloxacillin—Myalgia—Methotrexate—urinary bladder cancer	0.000899	0.00141	CcSEcCtD
Flucloxacillin—Arthralgia—Methotrexate—urinary bladder cancer	0.000899	0.00141	CcSEcCtD
Flucloxacillin—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000895	0.0014	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000893	0.0014	CcSEcCtD
Flucloxacillin—Malaise—Epirubicin—urinary bladder cancer	0.000891	0.0014	CcSEcCtD
Flucloxacillin—Discomfort—Methotrexate—urinary bladder cancer	0.000888	0.00139	CcSEcCtD
Flucloxacillin—Leukopenia—Epirubicin—urinary bladder cancer	0.000885	0.00139	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000862	0.00135	CcSEcCtD
Flucloxacillin—Convulsion—Epirubicin—urinary bladder cancer	0.000856	0.00134	CcSEcCtD
Flucloxacillin—Nausea—Etoposide—urinary bladder cancer	0.000855	0.00134	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000848	0.00133	CcSEcCtD
Flucloxacillin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000845	0.00132	CcSEcCtD
Flucloxacillin—Anaemia—Doxorubicin—urinary bladder cancer	0.000845	0.00132	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000844	0.00132	CcSEcCtD
Flucloxacillin—Myalgia—Epirubicin—urinary bladder cancer	0.000841	0.00132	CcSEcCtD
Flucloxacillin—Arthralgia—Epirubicin—urinary bladder cancer	0.000841	0.00132	CcSEcCtD
Flucloxacillin—Skin disorder—Methotrexate—urinary bladder cancer	0.000837	0.00131	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000835	0.00131	CcSEcCtD
Flucloxacillin—Discomfort—Epirubicin—urinary bladder cancer	0.000831	0.0013	CcSEcCtD
Flucloxacillin—Malaise—Doxorubicin—urinary bladder cancer	0.000825	0.00129	CcSEcCtD
Flucloxacillin—Leukopenia—Doxorubicin—urinary bladder cancer	0.000818	0.00128	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000806	0.00126	CcSEcCtD
Flucloxacillin—Convulsion—Doxorubicin—urinary bladder cancer	0.000792	0.00124	CcSEcCtD
Flucloxacillin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000791	0.00124	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00079	0.00124	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000785	0.00123	CcSEcCtD
Flucloxacillin—Skin disorder—Epirubicin—urinary bladder cancer	0.000783	0.00123	CcSEcCtD
Flucloxacillin—Myalgia—Doxorubicin—urinary bladder cancer	0.000778	0.00122	CcSEcCtD
Flucloxacillin—Arthralgia—Doxorubicin—urinary bladder cancer	0.000778	0.00122	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000773	0.00121	CcSEcCtD
Flucloxacillin—Discomfort—Doxorubicin—urinary bladder cancer	0.000769	0.00121	CcSEcCtD
Flucloxacillin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000759	0.00119	CcSEcCtD
Flucloxacillin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000749	0.00117	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000746	0.00117	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000744	0.00117	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000735	0.00115	CcSEcCtD
Flucloxacillin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000732	0.00115	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000731	0.00114	CcSEcCtD
Flucloxacillin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000725	0.00114	CcSEcCtD
Flucloxacillin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00071	0.00111	CcSEcCtD
Flucloxacillin—Dyspepsia—Epirubicin—urinary bladder cancer	0.00071	0.00111	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000705	0.0011	CcSEcCtD
Flucloxacillin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000701	0.0011	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000696	0.00109	CcSEcCtD
Flucloxacillin—Constipation—Epirubicin—urinary bladder cancer	0.00069	0.00108	CcSEcCtD
Flucloxacillin—Urticaria—Methotrexate—urinary bladder cancer	0.000685	0.00107	CcSEcCtD
Flucloxacillin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000681	0.00107	CcSEcCtD
Flucloxacillin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000681	0.00107	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00068	0.00107	CcSEcCtD
Flucloxacillin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000665	0.00104	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000659	0.00103	CcSEcCtD
Flucloxacillin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000657	0.00103	CcSEcCtD
Flucloxacillin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000649	0.00102	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000644	0.00101	CcSEcCtD
Flucloxacillin—Urticaria—Epirubicin—urinary bladder cancer	0.000641	0.001	CcSEcCtD
Flucloxacillin—Constipation—Doxorubicin—urinary bladder cancer	0.000638	0.001	CcSEcCtD
Flucloxacillin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000638	0.000999	CcSEcCtD
Flucloxacillin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000638	0.000999	CcSEcCtD
Flucloxacillin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000635	0.000995	CcSEcCtD
Flucloxacillin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000615	0.000964	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00061	0.000956	CcSEcCtD
Flucloxacillin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000594	0.000931	CcSEcCtD
Flucloxacillin—Urticaria—Doxorubicin—urinary bladder cancer	0.000593	0.000929	CcSEcCtD
Flucloxacillin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00059	0.000924	CcSEcCtD
Flucloxacillin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00059	0.000924	CcSEcCtD
Flucloxacillin—Diarrhoea—Methotrexate—urinary bladder cancer	0.00059	0.000924	CcSEcCtD
Flucloxacillin—Dizziness—Methotrexate—urinary bladder cancer	0.00057	0.000893	CcSEcCtD
Flucloxacillin—Diarrhoea—Epirubicin—urinary bladder cancer	0.000552	0.000865	CcSEcCtD
Flucloxacillin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00055	0.000861	CcSEcCtD
Flucloxacillin—Vomiting—Methotrexate—urinary bladder cancer	0.000548	0.000859	CcSEcCtD
Flucloxacillin—Rash—Methotrexate—urinary bladder cancer	0.000543	0.000851	CcSEcCtD
Flucloxacillin—Dermatitis—Methotrexate—urinary bladder cancer	0.000543	0.000851	CcSEcCtD
Flucloxacillin—Headache—Methotrexate—urinary bladder cancer	0.00054	0.000846	CcSEcCtD
Flucloxacillin—Dizziness—Epirubicin—urinary bladder cancer	0.000533	0.000836	CcSEcCtD
Flucloxacillin—Vomiting—Epirubicin—urinary bladder cancer	0.000513	0.000803	CcSEcCtD
Flucloxacillin—Nausea—Methotrexate—urinary bladder cancer	0.000512	0.000802	CcSEcCtD
Flucloxacillin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000511	0.0008	CcSEcCtD
Flucloxacillin—Rash—Epirubicin—urinary bladder cancer	0.000509	0.000797	CcSEcCtD
Flucloxacillin—Dermatitis—Epirubicin—urinary bladder cancer	0.000508	0.000796	CcSEcCtD
Flucloxacillin—Headache—Epirubicin—urinary bladder cancer	0.000505	0.000792	CcSEcCtD
Flucloxacillin—Dizziness—Doxorubicin—urinary bladder cancer	0.000493	0.000773	CcSEcCtD
Flucloxacillin—Nausea—Epirubicin—urinary bladder cancer	0.000479	0.000751	CcSEcCtD
Flucloxacillin—Vomiting—Doxorubicin—urinary bladder cancer	0.000474	0.000743	CcSEcCtD
Flucloxacillin—Rash—Doxorubicin—urinary bladder cancer	0.000471	0.000737	CcSEcCtD
Flucloxacillin—Dermatitis—Doxorubicin—urinary bladder cancer	0.00047	0.000737	CcSEcCtD
Flucloxacillin—Headache—Doxorubicin—urinary bladder cancer	0.000467	0.000733	CcSEcCtD
Flucloxacillin—Nausea—Doxorubicin—urinary bladder cancer	0.000443	0.000695	CcSEcCtD
